Strong Japan Sales Momentum
Aflac Japan delivered a 25.5% year-over-year increase in first-quarter sales, driven by new products including Onsen Tallett (medical) and Miraito (cancer insurance), and broad channel growth across agencies, alliance partners and banks.
Improved Adjusted Earnings Per Share
Adjusted earnings per diluted share increased year-over-year (Max: +6.6% to $1.77 excluding FX; company reported adjusted EPS of $1.75 and net EPS $1.98), reflecting solid execution and favorable reserve remeasurement gains of $82 million (about $0.04 per share above plan).
Solid U.S. Top-Line and Persistency
Aflac U.S. sales rose 2.9% year-over-year with net earned premium up 3.5% and strong premium persistency at 79.3%, supported by momentum in group voluntary products.
Attractive Profitability Metrics
Adjusted ROE was 12.8% (16.4% excluding foreign currency remeasurement). Japan pretax margin was 35% (up 320 basis points year-over-year); U.S. pretax margin remained solid at 20.4%.
Capital, Liquidity and Shareholder Returns
Unencumbered liquidity of $3.4 billion (about $2.4 billion above minimum), adjusted leverage at 21.2% (inside 20%-25% target), estimated regulatory ESR ~227% (243% with USP) and combined RBC ~560%. Returned ~$1.3 billion to shareholders in Q1 (approximately $1.0B repurchases + $315M dividends) and maintained 43 consecutive years of dividend increases.
Investment and Strategic Reinsurance Activity
Recorded strategic expansion of reinsurance franchise (Aflac Re Bermuda assumed a block from Japan Post Insurance) and management highlighted external reinsurance as a future growth/earnings diversification opportunity; variable net investment income and some fixed-rate income supported a 4% increase in adjusted net investment income in Japan (yen terms).
Favorable Benefit Ratio Drivers
Japan total benefit ratio improved to 62.9% (down 290 bps YoY, with ~70 bps benefit from reserve remeasurement gains). U.S. total benefit ratio was 47.2% (50 bps lower than Q1 2025), helped by favorable incurred claims in individual voluntary benefits and group disability.
Operating Execution in U.S. Group Business
Strong U.S. group product performance: group products up ~12.4% for the quarter, and a combined set of targeted categories (group life/absence/disability + consumer markets) up ~25%, with initiatives to improve agent onboarding and productivity.